Formulation and evaluation of stomach-specific amoxicillin-loaded carbopol-934P mucoadhesive microspheres for anti-Helicobacter pylori therapy

Journal of Microencapsulation

Volumn 26, Issue 4, 2009, Pages 365-376

  Patel, Jayvadan K ^a   Chavda, Jayant R ^b  

^a GANPAT UNIVERSITY   (India)

^b B K Mody Government Pharmacy College   (India)

Author keywords

Amoxicillin; Factorial design; H. pylori; Microspheres; Mucoadhesive

Indexed keywords

ADHESIVE AGENT; AMOXICILLIN; CARBOMER; ETHYL CELLULOSE; HYDROCHLORIC ACID; MICROSPHERE; PHOSPHATE BUFFERED SALINE; POLYMER; SOLVENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSAGE FORM COMPARISON; DRUG DOSE COMPARISON; DRUG FORMULATION; DRUG SCREENING; DRUG SPECIFICITY; DRUG STABILITY; DUODENUM ULCER; EMULSION; EVAPORATION; FACTORIAL DESIGN; GASTROINTESTINAL TRACT; HELICOBACTER INFECTION; HELICOBACTER PYLORI; MALE; NONHUMAN; PARTICLE SIZE; RAT; SCANNING ELECTRON MICROSCOPE; SINGLE DRUG DOSE; STOMACH MUCOSA; STOMACH ULCER; SUSTAINED DRUG RELEASE;

ACRYLATES; AMOXICILLIN; ANIMALS; ANTI-BACTERIAL AGENTS; DUODENAL ULCER; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MICROSPHERES; PARTICLE SIZE; RATS; RATS, WISTAR; STOMACH; STOMACH ULCER;

EID: 70849131700     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.1080/02652040802373012     Document Type: Article

References (50)

1. Gohel MC, Amin AF. Formulation optimization of controlled release diclofenac sodium microspheres using factorial design. J Contr Rel. 1998;51:115-122
2. Woo BH, Jiang G, Jo YW, DeLuca PP. Preparation and characterization of a composite PLGA and poly (acryloyl hydroxymethyl starch) microsphere system for protein delivery. Pharm Res. 2001;18:1600-1606
3. Capan Y, Jiang G, Giovagnoli S, DeLuca PP. Preparation and characterization of poly (D,L-lactide-co-glycolide) microsphere for controlled release of human growth hormone. AAPS PharmSciTech. 2003;4:article 28.
4. Vasir JK, Tambwekar K, Garg S. Bioadhesive microspheres as a controlled drug delivery system. Int J Pharm. 2003;255:13-32.
5. Ikeda K, Murata K, Kobayashi M, Noda K. Enhancement of bioavailability of dopamine via nasal route in beagle dogs. Chem Pharm Bull. 1992;40:2155-2158
6. Schaefer MJ, Singh J. Effect of isopropyl myristic acid ester on the physical characteristics and in-vitro release of etoposide from PLGA microspheres. AAPS PharmSciTech. 2000;1:article 32.
7. Govender S, Pillay V, Chetty DJ, Essack SY, Dangor CM, Govender T. Optimisation and characterisation of bioadhesive controlled release tetracycline microspheres. Int J Pharm. 2005;306:24-40.
8. Patel JK, Patel RP, Amin AF, Patel MM. Formulation and evaluation of mucoadhesive glipizide microspheres. AAPS PharmSciTech. 2005; 06:E49-55.
9. Lehr CM, Bouwstra JA, Schacht EH, Junginger HE. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int J Pharm. 1992;78:43-48
10. Henriksen L, Green KL, Smart JD, Smistad G, Karlsen J. Bioadhesion of hydrated chitosans: An in vitro and in vivo study. Int J Pharm. 1996;145:231-240
11. Rao SB, Sharma CP. Use of chitosan as biomaterial: Studies on its safety and hemostatic potential. J Biomed Mater Res. 1997;34:21-28
12. Chowdary KPR, Rao YS. Design and in vitro and in vivo evaluation of mucoadhesive microcapsules of glipizide for oral controlled release: A technical note. AAPS PharmSciTech. 2003;4:article 39.
13. Chickering D, Jacob J, Mathiowitz E. Bioadhesive microspheres II. Characterization and evaluation of bioadhesion involving hard, bioerodiable polymers and soft tissue. Reactive Polym. 1995; 25:198-206.
14. Chun MK, Cho CS, Choi HK. Mucoadhesive drug carrier based on interpolymer complex of poly(vinyl pyrrolidone) and poly(acrylic acid) prepared by template polymerization. J Contr Rel. 2002; 17:327-334
15. Chun M-K, Cho C-S, Choi H-K. Mucoadhesive microspheres prepared by interpolymer complexation and solvent diffusion method. Int J Pharm. 2005;288:295-303.
16. Blanco-Fuente H, Anguiamo-Igea S, Otero-Espinar FJ, Blanco- M'endez J. In vitro bioadhesion of carbopol hydrogel. Int J Pharm. 2004;276:51-58
17. Liu Z, Lu W, Qian L, Zhang X, Zeng P, Pan J. In vitro and in vivo studies on mucoadhesive microspheres of amoxicillin. J Contr Rel. 2005;102:135-144 (Pubitemid 40093780)
18. Warren JR, Marshall B. Unified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1983;321:1273-1275
19. Magraud F, Lamouliatte H. Helicobacter pylori and duodenal ulcers. Dig Dis Sci. 1992;37:769-772
20. Forman D, Webb P, Personnet J. H. pylori and gastric cancer. Lancet. 1994;343:243-244
21. Forman D, Newell F, Fullerton J, Yarnell A, Stacey N, Wald S. Association between infection with Helicobacter pylori and risk of gastric cancer: Evidence from a prospective investigation. Br Med J. 1991;302:302-305
22. Blaser M. Ecology of Helicobacter pylori in the human stomach. J Clin Invest. 1997;100:759-762 (Pubitemid 27371691)
23. Malfertheiner P, Megraud C, O'Morain A, Hungin R, Jones A, Axon D, et al. European Helicobacter Pylori Study Group (EHPSG). Current concepts in the management of Helicobacter pylori infection - the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther. 2002; 16:167-180
24. Gisbert J, Pajares J. Helicobacter pylori therapy: First-line options and rescue regimen. Dig Dis. 2001;19:134-143
25. Jenks P, Edwards D. Metronidazole resistance in Helicobacter pylori. Int J Antimicrob Agents. 2002;19:1-7.
26. Osato M, Reddy S, Reddy R, Penland R, Malaty H, Graham D. Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States. Arch Intern Med. 2001; 161:1217-1220 (Pubitemid 32691518)
27. Wu H, Shi XD, Wang HT, Liu JX. Resistance of Helicobacter pylori to metronidazole, tetracycline and amoxycillin. J Antimicrob Chemother. 2000;46:121-123
28. Kwon D, Kim J, Lee M, Yamaoka M, Kato M, Osato F, et al. Isolation and characterization of tetracycline-resistant clinical isolates of Helicobacter pylori. Antimicrob Agents Chemother. 2000;44:3203-3205
29. Buzas GM, Szekely E. Eradication of Helicobacter pylori in peptide ulcer patients. Orv Hetil. 1999;140:121-124
30. Suleymanlar I, Tuncer M, Tugrul MS, Erttugrul C, Sarikaya M, Fevzi FE, et al. Response to triple treatment with omeprazole, amoxicillin and clarithromycin for Helicobacter pylori infections in continuous ambulatory peritoneal dialysis patients. Adv Perit Dial. 1999;15:79-81.
31. Vakil N, Cutler A. Ten-day triple therapy with ranitidine, bismuthcitrate, amoxicillin and clarithromycin in eradicating Helicobacter pylori. Am J Gastroenterol. 1999;94:1197-1199
32. Kawabami E, Ogata SK, Portorreal AC. Triple therapy with clarithromycin amoxicillin and omeprazole for Helicobacter pylori in eradication in children and adolescents. Arq Gastroenterol. 2001; 38:203-206
33. Lin CK, Hsu PI, Lai KH. One-week quadruple therapy is an effective salvage regiment for Helicobacter pylori infection in patients after failure of standard triple therapy. J Clin Gastroenterol. 2002; 34:547-551
34. Cooreman MP, Krausgrill P, Hengels KJ. Local gastric and serum amoxicillin concentrations after different oral application forms. Antimicrob Agents Chemother. 1993;37:1506-1509
35. Atherton JC, Cockayne A, Balsitis M, Kirk GE, Hawley CJ, Spiller RC. Detection of the intragastric sites at Helicobacter pylori evades treatment with amoxicillin and cimetidine. Gut. 1995;36:670-674
36. Axon AT. The role of acid inhibition in the treatment of Helicobacter pylori infection. Scand J Gastroenterol. 1994;29:16-23.
37. Giacomo F, Marinano L, Silvana M, Domenico S, Gaetano G. Amoxicillin-loaded polyethylcyanoacrylate nanoparticles: Influence PEG coating on the particle size, drug release rate and phagocytic uptake. Biomaterials. 2001;22:2857-2865
38. Hilton AK, Deasy PB. In vitro and in vivo evaluation of an oral sustained- release floating dosage form of amoxicillin trihygrate. Int J Pharm. 1992;86:79-88.
39. Nagahara N, Akiyama Y, Nako M, Tada M, Kitano M, Ogawa Y. Mucoadhesive microspheres containing amoxicillin for clearance of Helicobacter pylori. Antimicrob Agent Chemother. 1998; 42:2492-2494
40. Patel JK, Patel MM. Stomach specific anti-Helicobacter Pylori therapy- preparation and evaluation of amoxicillin loaded chitosan mucoadhesive microspheres. Curr Drug Deliv. 2007;4:41-51.
41. Eugene L. Milling. In: Lachman L, Liberman HA, editors. The theory and practice of industrial pharmacy. 2nd ed. Mumbai: Varghese publishing house; 1991. pp 26-27
42. Lehr CM, Bowstra JA, Tukker JJ, Junginger HE. Intestinal transit of bioadhesive microspheres in an in situ loop in the rat. J Contr Rel. 1990;13:51-62.
43. Dokoumetzidis A, Papadopoulou V, Macheras P. Analysis of dissolution data using modified versions of Noyes-Whitney equation and the Weibull function. Pharm Res. 2006;23:256-261
44. Korsemeyer R, Gurny R, Peppas N. Mechnisums of solute release from porous hydrophilic polymers. Int J Pharm. 1983; 15:25-35.
45. Karasulu E, Karasuslu HY, Ertan G, Kirilmaz L, Guneri T. Extended release lipophillic indomethacin microspheres: Formulation factors and mathematical equations fitted drug release rates. Eur J Pharm Sci. 2003;19:99-104.
46. Lee JW, Park JH, Robinson JR. Bioadhesive-based dosage forms: The next generation. J Pharm Sci. 2000;89:850-866
47. Ogwal S, Xide TU. Bioavailability and stability of erythromycin delayed release tablets. Afr Health Sci. 2001;2:90-96
48. Erach PO, Goddard AF, Barrett DA, Shaw PN, Spiller RC. The stability of amoxicillin, clarithromycin and metronidazole in gastric juice: Relevance to the treatment of Helicobacter pylori infection. J Antimicrob Chemother. 1997;39:5-12.
49. Mascher C, Kikuta C. Determination of amoxicillin in human serum and plasma by high-performance liquid chromatography and on-line postcolumn derivatisation. J Chromatogr A. 1998; 182:221-226
50. Chadha R, Kashid N, Jain DV. Kinetic studies of the degradation of an aminopenicillin antibiotic in aqueous solution using heat conduction microcalorimerty. J Pharm Pharmcol. 2003;55:1495-1503